Oxelumab is a human monoclonal antibody designed for the treatment of asthma.[1]

Oxelumab was developed by Genentech and co-developed by Roche.

References

  1. ^ "Statement On A Nonproprietary Name Adopted By The USAN Council: Oxelumab" (PDF). American Medical Association. Archived from the original (PDF) on 12 May 2013.
Allikas: https://en.wikipedia.org/wiki/Oxelumab
No tags for this post.